Noul Co.,Ltd. (KOSDAQ:376930)
South Korea · Delayed Price · Currency is KRW 1,670.00
+385.00 (29.96%)
At close: Oct 23, 2026
Noul Co.,Ltd. Revenue
Noul Co.,Ltd. had revenue of 1.01B KRW in the quarter ending June 30, 2026, a decrease of -28.03%. This brings the company's total for the last twelve months to 3.66B, down -12.74% year-over-year. In the year 2025, Noul Co.,Ltd. had annual revenue of 5.12B with 219.83% growth. That makes Noul Co.,Ltd. the 41,631st largest company in the world by revenue and 2,542nd in South Korea.
Revenue (ttm)
3.66B
Revenue Growth
-12.74%
P/S Ratio
4.68
Revenue / Employee
35.17M
Employees
104
Market Cap
17.13B
Revenue by Geography
- Africa 2.20B 43.0%
- North and Central America 1.39B 27.1%
- Europe 614.52M 12.0%
- South Korea 587.18M 11.5%
- Middle East 251.72M 4.9%
- Asia 74.63M 1.5%
Fiscal year ended Dec 31, 2025 See the full Noul Co.,Ltd. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.12B | 3.52B | 219.83% |
| Dec 31, 2024 | 1.60B | -1.13B | -41.42% |
| Dec 31, 2023 | 2.73B | 2.19B | 404.51% |
| Dec 31, 2022 | 541.88M | -933.43M | -63.27% |
| Dec 31, 2021 | 1.48B | 1.18B | 399.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 107.88B |
| CU Medical Systems | 62.40B |
| JPI Healthcare | 46.86B |
| Bistos | 16.08B |
| MEKICS CO., | 13.76B |
| DHX Company | 13.66B |
| NANOOMTECH | 6.51B |
| Genesystem | 1.01B |